TABLE 2.

Log changes in viable cell counts at various time points with clinically relevant ELF concentrations of meropenem and/or tobramycin^a

^aMER, meropenem; TOB, tobramycin; CFU_t, number of CFU at time t; CFU₀, number of CFU at time zero. The green background indicates synergy (a ≥2-log₁₀ decrease in the number of CFU per milliliter or the number of CFU per square centimeter with the combination compared to the value for its most active component); the blue background indicates a 1.0- to <2-log₁₀ decrease in the number of CFU per milliliter or the number of CFU per square centimeter with the combination compared to the value for its most active component.